[The action of medikhronal (glucose-glycine-formate) on catecholamine excretion in alcoholics].
The application of the novel antialcoholic drug Medichronal mainly results in normalization of dyscatecholaminemias, by lowering or elevating noradrenaline or adrenaline levels. This effect is similar to that produced by unitiol that is conventionally used in nacrological care. The changes in catecholamine levels occur in various dyscatecholaminemias characterized by a high or low excretion of biogenic monoamines. Before and after therapy, in some patients, the concentrations of catecholamines do not differ from those in healthy persons.
Bozhko
G Kh
GKh
Voloshin
P V
PV
Boĭko
T P
TP
Markozova
L M
LM
Bolotova
Z N
ZN
D000079:Acetaldehyde / Q000037:antagonists & inhibitors*; D000328:Adult; D000427:Alcohol Deterrents / Q000627:therapeutic use*; D000437:Alcoholism / Q000188:drug therapy* / Q000652:urine; D002395:Catecholamines / Q000652:urine*; D004338:Drug Combinations; D004341:Drug Evaluation; D005561:Formates / Q000627:therapeutic use*; D005947:Glucose / Q000627:therapeutic use*; D005998:Glycine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D014494:Unithiol / Q000627:therapeutic use
D000427:Alcohol Deterrents; D002395:Catecholamines; D004338:Drug Combinations; D005561:Formates; C088648:medikhronal; D014494:Unithiol; D000079:Acetaldehyde; D005947:Glucose; D005998:Glycine
Deĭstvie medikhronala (gliuzkozo-glitsin-formiata) na ékskretsiiu katekholaminov u bol'nykh alkogolizmom.